It is essential to highlight that although no meta-analysis was performed to evaluate the association of ERS biomarkers with diabetes complications due to the paucity of studies, the evidence from single studies suggests an independent association of serum PRX4 levels with mortality in T2D [52] and incident diabetes [41]. Here, PRDX4 is linked to type 2 diabetes mellitus.